SAB Biotherapeutics, Inc. (SABS): 10-Q filed Nov 5, 2026

Form type

10-Q

Filing date

Nov 5, 2026

Accession number

0001193125-26-448600

Filer

SAB Biotherapeutics, Inc. (CIK 1833214)